These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6688150)

  • 1. Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Thigpen JT; Blessing J; Homesley HD; Adcock LL
    Am J Clin Oncol; 1983 Aug; 6(4):423-6. PubMed ID: 6688150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary. A Gynecologic Oncology Group study.
    Thigpen JT; Blessing JA; Arseneau JC; Homesley HD
    Am J Clin Oncol; 1984 Jun; 7(3):261-3. PubMed ID: 6547268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    Thigpen JT; Ehrlich CE; Conroy J; Blessing JA
    Am J Clin Oncol; 1983 Aug; 6(4):427-30. PubMed ID: 6869315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; Lagasse L; Blessing J
    Cancer; 1981 Aug; 48(4):899-903. PubMed ID: 7196794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Homesley HD; Lewis GC
    Gynecol Oncol; 1986 Mar; 23(3):358-63. PubMed ID: 3754234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma. A Gynecologic Oncology Group study.
    Thigpen JT; Blessing JA; Homesley HD; Hacker N; Curry SL
    Am J Clin Oncol; 1985 Oct; 8(5):350-2. PubMed ID: 3840643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Fowler WC; Hatch K
    Cancer Treat Rep; 1986 Sep; 70(9):1097-100. PubMed ID: 3755650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology Group.
    Conroy JF; Lewis GC; Blessing JA; Mangan C; Hatch K; Wilbanks G
    Am J Clin Oncol; 1984 Apr; 7(2):131-3. PubMed ID: 6702716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology Group.
    Thigpen JT; Lagasse L; Homesley H; Blessing JA
    Am J Clin Oncol; 1983 Aug; 6(4):431-5. PubMed ID: 6683465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of piperazinedione in the treatment of advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study.
    Thigpen JT; Blessing JA; Homesley HD; Petty W
    Am J Clin Oncol; 1986 Feb; 9(1):21-3. PubMed ID: 3754086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Bonomi P; Blessing J; Ball H; Hanjani P; DiSaia PJ
    Gynecol Oncol; 1989 Sep; 34(3):357-9. PubMed ID: 2767528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG).
    Muss HB; Blessing JA; Eddy GL; McGehee R
    Invest New Drugs; 1992 Apr; 10(1):25-6. PubMed ID: 1607251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of advanced squamous carcinoma of the cervix: a phase I-II study of high-dose cisplatin and cyclophosphamide. A pilot study of the Gynecologic Oncology Group.
    Jobson VW; Muss HB; Thigpen JT; Homesley HD; Bundy B
    Am J Clin Oncol; 1984 Aug; 7(4):341-5. PubMed ID: 6540048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group study.
    Al-Sarraf M; Thigpen T; Groppe CW; Haut A; Padilla F
    Cancer Treat Rep; 1978 Jul; 62(7):1101-3. PubMed ID: 356973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group study.
    Lincoln S; Blessing JA; McGehee R; Lentz SS
    Am J Clin Oncol; 1997 Feb; 20(1):84-5. PubMed ID: 9020296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of piperazinedione in metastatic breast carcinoma.
    Palmer RL; Samal BA; Vaughn CB; Tranum BL
    Cancer Treat Rep; 1977 Dec; 61(9):1711-2. PubMed ID: 340035
    [No Abstract]   [Full Text] [Related]  

  • 18. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
    Weiss GR; Green S; Hannigan EV; Boutselis JG; Surwit EA; Wallace DL; Alberts DS
    Gynecol Oncol; 1990 Dec; 39(3):332-6. PubMed ID: 2258080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of piperazinedione in metastatic sarcoma.
    Presant CA; Bartolucci AA
    Am J Clin Oncol; 1982 Apr; 5(2):185-7. PubMed ID: 7046413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.